24 results for “market”
A data and economics specialist working across Germany’s medical cannabis sector will join the Cannabis Health Symposium Frankfurt later this year.
A senior figure behind one of Germany’s medical cannabis telemedicine platforms has been announced as a speaker at an event hosted by Cannabis Health later this year.
Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, […]
Exilby® has received market authorisation in Germany and Austria, with UK approval expected by the end of the year.
More than 70 international speakers and over 1000 delegates are set to convene on London next month for policy debates, high-level networking, and the 2026 Business of Cannabis Awards.
Polish pharmacies dispensed nearly 5,450 kilograms of dried cannabis flower in 2025, a 12% increase from the prior year, according to new data obtained by Prohibition Partners. By October, monthly volumes […]
A new initiative is giving patients a direct voice in how the UK’s medical cannabis market is shaped.
In the first of a series of deep dives in the UK market, we look into its rapid growth, the shift in dominance of popular strains, and the dramatic swing towards higher THC products.
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging […]
Findings from The European Cannabis Report: 10th Edition reflect a decade of immense change across European cannabis markets.
Switzerland has approved a draft proposal to establish a fully commercial adult-use cannabis market.
The number of items prescribed in the UK’s private medical cannabis market has doubled each year since 2021.
The Czech government looks to be pursuing a full commercial adult-use cannabis market as part of its ‘Cannabis Management Act’, according to leaked documents seen by Business of Cannabis. It came […]
James Leavesley and Brady Green, head grower at Dalgety, discuss what insights the UK can glean from more advanced markets.
The non-irradiated cannabis flower is expected to be available on prescription for patients this month.
Dave Barton, co-founder and creative director at cannabis content agency, thermidor<, explores the challenges brands face in marketing medical cannabis and wonders whether any of them are actually doing it […]
Head grower at Dalgety, Brady Green, explores the difference between prescribed cannabis and its illegal counterpart.
With a renewed focus on the recreational market, could the country’s medical cannabis patients get left behind?
There is currently only one consultant who specialises in paediatric epilepsy prescribing cannabis in the UK
Terpenes extracted from fruits, plants and herbs play a vital role in aromatherapy
The brand is bringing new energy to the UK CBD market
Cannabis journalist, Ruby Deevoy, has tried and tested her fair share of CBD oils, here she shares her top five.
The product has been described as a “unique” addition to oral healthcare.
The company helps international cultivators break into the continent’s growing sector
